A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
Conditions
- B-Cell ALL
- B-Cell Acute Lymphoblastic Leukaemia
- B-Cell Lymphoblastic Leukemia
- B-Cell Lymphoblastic Leukemia/Lymphoma
- B-cell Acute Lymphoblastic Leukemia (B-ALL)
- B-cell Acute Lymphoblastic Leukemia
- B-cell Childhood Acute Lymphoblastic Leukemia
- B-cell Leukemia
Sponsor
Arkansas Children's Hospital Research Institute
Collaborators